Deutsche Bank keeps Spyre Therapeutics at Buy
Deutsche Bank maintains a Buy rating on Spyre Therapeutics.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Deutsche Bank maintains a Buy rating on Spyre Therapeutics.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.